Trial Profile
Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Jul 2015
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 30 Jul 2015 New trial record